Search

everythinglearnresearchcommunity

for

Search:↓

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Certain pesticides and fungicides can interfere with male hormone functions, potentially causing reproductive issues in male rats.

Hair loss in androgenic alopecia may be linked to increased local androgen activities, but not to estrogen levels.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

The mouse models are effective for testing new hair loss treatments.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

New genes linked to male pattern baldness were found on chromosome 20p11.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Curcuma aeruginosa Roxb. may help treat hair loss by affecting specific biological pathways.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

NMN could potentially treat hair loss by reducing oxidative stress and improving cell health.

Chromosomal differences affect how muscle cells respond to testosterone.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

Androgen receptor degrader drugs may be a promising future treatment for hair loss.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Exosomes from certain stem cells can promote hair growth and counteract hair loss caused by hormones by regulating growth factors and other cellular signals.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.